{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:01:35Z","timestamp":1792612895411,"version":"4.5.0"},"reference-count":37,"publisher":"Impact Journals, LLC","issue":"40","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,10,4]]},"DOI":"10.18632\/oncotarget.11673","type":"journal-article","created":{"date-parts":[[2016,8,29]],"date-time":"2016-08-29T15:31:39Z","timestamp":1472484699000},"page":"65284-65294","source":"Crossref","is-referenced-by-count":40,"title":["GATA3 expression correlates with poor prognosis and tumor-associated macrophage infiltration in peripheral T cell lymphoma"],"prefix":"10.18632","volume":"7","author":[{"given":"Wei","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Hematology, Peking Union Medical College (PUMC) Hospital, Chinese Academy of Medical Sciences and PUMC, Beijing, 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Peking Union Medical College (PUMC) Hospital, Chinese Academy of Medical Sciences and PUMC, Beijing, 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunping","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Immunology, Institute of Basic Medical Science, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingrong","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Pathology, PUMC Hospital, Chinese Academy of Medical Sciences and PUMC, Beijing, 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Pathology, PUMC Hospital, Chinese Academy of Medical Sciences and PUMC, Beijing, 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daobin","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Hematology, Peking Union Medical College (PUMC) Hospital, Chinese Academy of Medical Sciences and PUMC, Beijing, 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,8,29]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1023\/A:1008265532487","article-title":"Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project","volume":"9","author":"Weisenburger","year":"1998","journal-title":"Ann OncoL"},{"key":"2","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1038\/modpathol.2012.181","article-title":"Peripheral T-cell and NK-cell lymphomas in the WHO classification: pearls and pitfalls","volume":"26","author":"Pittaluga","year":"2013","journal-title":"Mod Pathol"},{"key":"3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.beha.2013.04.003","article-title":"International analysis of the frequency and outcomes of NK\/T-cell lymphomas","volume":"26","author":"Armitage","year":"2013","journal-title":"Best Pract Res Cl Ha"},{"key":"4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1309\/AJCP0SBHYVLY5EML","article-title":"Expression of Master Regulators of Helper T-Cell Differentiation in Peripheral T-Cell Lymphoma, Not Otherwise Specified, by Immunohistochemical Analysis","volume":"133","author":"Taniwaki","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"5","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1182\/blood-2013-11-536359","article-title":"Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma","volume":"123","author":"Tan","year":"2014","journal-title":"Blood"},{"key":"6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrc1256","article-title":"Tumour-educated macrophages promote tumour progression and metastasis","volume":"4","author":"Pollard","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2217\/1750743X.1.1.83","article-title":"Tumor-associated macrophages as targets for tumor immunotherapy","volume":"1","author":"Brune","year":"2009","journal-title":"Immunotherapy-Uk"},{"key":"8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3109\/10428194.2010.529204","article-title":"Expression of tumor-associated macrophages and vascular endothelial growth factor correlates with poor prognosis of peripheral T-cell lymphoma, not otherwise specified","volume":"52","author":"Wu","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"9","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood-2013-12-544809","article-title":"GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features","volume":"123","author":"Witzig","year":"2014","journal-title":"Blood"},{"key":"10","first-page":"878","article-title":"Peripheral T-cell lymphoma: new therapeutic strategies","volume":"27","author":"Rosen","year":"2013","journal-title":"Oncology (Williston Park)"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2262","article-title":"CHOP or THP-COP regimens in the treatment of newly diagnosed peripheral T-cell lymphoma, not otherwise specified: a comparison of doxorubicin and pirarubicin","author":"Kito","year":"2015","journal-title":"Hematol Oncol"},{"key":"12","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.6004\/jnccn.2014.0125","article-title":"Non-Hodgkin's lymphomas, version 4. 2014","volume":"12","author":"Harris","year":"2014","journal-title":"J Natl Compr Canc Netw"},{"key":"13","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1182\/blood-2013-12-542142","article-title":"Objective responses in relapsed T-cell lymphomas with single-agent brentuximab vedotin","volume":"123","author":"Oki","year":"2014","journal-title":"Blood"},{"key":"14","first-page":"716","article-title":"Final report of a phase 2 clinical trial of lenalidomide monotherapy for patients with T-cell lymphoma","volume":"121","author":"Reiman","year":"2015","journal-title":"Cancer-Am Cancer Soc"},{"key":"15","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1200\/JCO.2011.37.4223","article-title":"Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy","volume":"30","author":"Shustov","year":"2012","journal-title":"J Clin Oncol"},{"key":"16","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1200\/JCO.2010.29.9024","article-title":"Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study","volume":"29","author":"Furman","year":"2011","journal-title":"J Clin Oncol"},{"key":"17","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Marti","year":"2000","journal-title":"Nature"},{"key":"18","first-page":"399","article-title":"Germinal center B cell-like (GCB) and activated B cell-like (ABC) type of diffuse large B cell lymphoma (DLBCL): analysis of molecular predictors, signatures, cell cycle state and patient survival","volume":"3","author":"Dandekar","year":"2007","journal-title":"Cancer Inform"},{"key":"19","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"Averett","year":"2002","journal-title":"N Engl J Med"},{"key":"20","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/path.1924","article-title":"Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma","volume":"208","author":"Oudejans","year":"2006","journal-title":"J Pathol"},{"key":"21","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Smith","year":"2004","journal-title":"Blood"},{"key":"22","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1158\/1078-0432.CCR-09-0113","article-title":"A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy","volume":"15","author":"Fu","year":"2009","journal-title":"Clin Cancer Res"},{"key":"23","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0952-7915(02)00340-0","article-title":"T helper cell differentiation: on again, off again","volume":"14","author":"Locksley","year":"2002","journal-title":"Curr Opin Immunol"},{"key":"24","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","article-title":"The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells","volume":"109","author":"Gaulard","year":"2007","journal-title":"Blood"},{"key":"25","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1038\/sj.leu.2403965","article-title":"FOXP3, a selective marker for a subset of adult T-cell leukaemia\/lymphoma","volume":"19","author":"Piris","year":"2005","journal-title":"Leukemia"},{"key":"26","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJM199910073411503","article-title":"Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia","volume":"341","author":"Blaser","year":"1999","journal-title":"N Engl J Med"},{"key":"27","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1182\/blood-2014-07-590398","article-title":"Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation","volume":"125","author":"Fuschiotti","year":"2015","journal-title":"Blood"},{"key":"28","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa0905680","article-title":"Tumor-associated macrophages and survival in classic Hodgkin's lymphoma","volume":"362","author":"Muller-Hermelink","year":"2010","journal-title":"N Engl J Med"},{"key":"29","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3324\/haematol.2010.033316","article-title":"Macrophages predict treatment outcome in Hodgkin's lymphoma","volume":"96","author":"Gascoyne","year":"2011","journal-title":"Haematologica"},{"key":"30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1631\/jzus.B1400184","article-title":"MicroRNAs in breast cancer: oncogene and tumor suppressors with clinical potential","volume":"16","author":"Luo","year":"2015","journal-title":"J Zhejiang Univ Sci B"},{"key":"31","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1146\/annurev.immunol.23.021704.115821","article-title":"Regulation of Th2 differentiation and Il4 locus accessibility","volume":"24","author":"Rao","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"32","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S1074-7613(00)80671-8","article-title":"Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism","volume":"9","author":"Murphy","year":"1998","journal-title":"Immunity"},{"key":"33","first-page":"13","article-title":"The M1 and M2 paradigm of macrophage activation: time for reassessment","volume":"6","author":"Gordon","year":"2014","journal-title":"F1000Prime Rep"},{"key":"34","first-page":"624040","article-title":"Peripheral T-cell lymphoma: review and updates of current management strategies","volume":"2010","author":"Lim","year":"2010","journal-title":"Adv Hematol"},{"key":"35","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1309\/AJCPWKJ3GPFRT7GA","article-title":"Analysis of 142 Northern Chinese Patients With Peripheral T\/NK-Cell Lymphomas: Subtype Distribution, Clinicopathologic Features, and Prognosis","volume":"138","author":"Li","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"36","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/j.ajpath.2013.01.025","article-title":"Epstein-Barr virus-encoded miR-BART20-5p inhibits T-bet translation with secondary suppression of p53 in invasive nasal NK\/T-cell lymphoma","volume":"182","author":"Lin","year":"2013","journal-title":"Am J Pathol"},{"key":"37","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1056\/NEJMe1502660","article-title":"Out of the orphanage and into the clinic\u2014therapeutic targeting of GATA3","volume":"372","author":"Schleimer","year":"2015","journal-title":"N Engl J Med"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11673","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T12:29:02Z","timestamp":1594816142000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,29]]},"references-count":37,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2016,10,4]]}},"alternative-id":["11673","27589565"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.11673","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,29]]}}}